Tudor Investment Corp’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-2,190
Closed -$22.8K 3023
2024
Q3
$22.8K Sell
2,190
-3,208
-59% -$53.3K ﹤0.01% 2630
2024
Q2
$106K Hold
5,398
﹤0.01% 2202
2024
Q1
$138K Hold
5,398
﹤0.01% 2079
2023
Q4
$149K Sell
5,398
-3,438
-39% -$210K ﹤0.01% 2233
2023
Q3
$537K Buy
8,836
+6,351
+256% +$446K 0.01% 1640
2023
Q2
$164K Sell
2,485
-13,715
-85% -$1M ﹤0.01% 2259
2023
Q1
$1.03M Sell
16,200
-3,595
-18% -$411K 0.02% 1178
2022
Q4
$2.74M Buy
19,795
+12,086
+157% +$1.7M 0.05% 465
2022
Q3
$976K Sell
7,709
-1,082
-12% -$122K 0.02% 929
2022
Q2
$728K Buy
8,791
+59
+0.7% +$4.58K 0.02% 1072
2022
Q1
$847K Buy
+8,732
New +$1.15M 0.02% 982
2021
Q3
Sell
-9,182
Closed -$3.8M 2463
2021
Q2
$3.8M Sell
9,182
-5,031
-35% -$1.99M 0.07% 324
2021
Q1
$5.55M Buy
14,213
+9,546
+205% +$4.7M 0.11% 159
2020
Q4
$2.62M Buy
4,667
+2,705
+138% +$1.71M 0.07% 322
2020
Q3
$1.37M Sell
1,962
-299
-13% -$233K 0.06% 449
2020
Q2
$1.79M Buy
+2,261
New +$1.7M 0.09% 288
2017
Q3
Sell
-320
Closed -$436K 1095
2017
Q2
$436K Buy
+320
New +$386K 0.01% 615
2016
Q4
Sell
-348
Closed -$306K 1398
2016
Q3
$306K Sell
348
-432
-55% -$313K 0.01% 1005
2016
Q2
$437K Buy
+780
New +$442K 0.01% 928
2016
Q1
Sell
-1,930
Closed -$1.6M 1744
2015
Q4
$1.6M Buy
+1,930
New +$1.93M 0.05% 270
2015
Q3
Sell
-757
Closed -$1.65M 1542
2015
Q2
$1.65M Buy
757
+286
+61% +$583K 0.05% 252
2015
Q1
$737K Sell
471
-203
-30% -$268K 0.02% 514
2014
Q4
$801K Buy
+674
New +$450K 0.03% 460

Other funds holding BLUE

Tudor Investment Corp's BLUE Position: Q4 2024 in Review

Tudor Investment Corp sold out of bluebird bio (BLUE) in Q4 2024, closing a stake of 2,190 shares — an estimated $22.8K sold.

Tudor Investment Corp first reported a position in BLUE in Q4 2014 and held it in 23 quarters. The position peaked at $5.55M in Q1 2021. 83 funds tracked by Wall St. Rank hold BLUE as of Q4 2024.

  • Tudor Investment Corp reported no remaining bluebird bio position as of Q4 2024 after selling out during the quarter.
  • Tudor Investment Corp sold 2,190 bluebird bio shares in Q4 2024, an estimated $22.8K.
  • Tudor Investment Corp first reported a position in bluebird bio in Q4 2014 and held it in 23 quarters.
  • Tudor Investment Corp's bluebird bio position peaked at $5.55M in Q1 2021.
  • 83 funds tracked by Wall St. Rank held bluebird bio as of Q4 2024.

Based on Tudor Investment Corp's 13F filing for Q4 2024, filed 14 Feb 2025.